ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.

    G. Malat,4 S. DiLollo,1 D. Lee,2 A. Sharma,3 T. Bias,2 M. Harhay,3 K. Ranganna,3 A. Doyle.3

    1Colonia Natural Pharmacy, Colonia; 2Medicine/Surgery, Drexel University, Philadelphia.

    Introduction We describe the implementation of a vaccine initiative in an ambulatory transplant setting.Methods In 2014, Hahnemann University Hospital (HUH) and Colonia Natural Pharmacy transplant…
  • 2016 American Transplant Congress

    High Tacrolimus Dose Requirements at Month 6 Are Associated with Inferior Graft Function in Renal Transplant Patients.

    O. Rissling, S. Brakemeier, L. Lehner, F. Halleck, O. Staeck, D. Schmidt, K. Budde.

    Department of Nephrology, Charité Universitaetsmedizin, Berlin, Germany.

    Introduction: Tacrolimus (Tac), the mainstay of immunosuppression in renal transplant (tx) patients (pts) is known for drug induced nephrotoxicity, which may limit graft survival.Methods: In…
  • 2016 American Transplant Congress

    High KDPI Is a Predictor of Acute Rejection in Delayed Graft Function.

    B. Muth,1 J. Turk,1 S. Parajuli,1 D. Mandelbrot,1 M. Mohamed,1 R. Redfield,2 D. Kaufman,2 A. Djamali.1,2

    1Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI; 2Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, WI.

    The kidney donor profile index (KDPI) is a prognostic measure for graft function and survival. It is unclear whether it predicts acute rejection in patients…
  • 2016 American Transplant Congress

    Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?

    D. Khadzhynov, F. Halleck, L. Lehner, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.

    Nephrology, Charite Universitaetsmedizin, Berlin, Germany.

    Background: Coronary artery disease is a frequent comorbidity among transplant candidates. Limited data exist on the long-term outcomes of kidney transplant recipients (KTR) with pre-existing…
  • 2016 American Transplant Congress

    Patients Treated with Belatacept Show Low Levels of APRIL and HLA Antibodies.

    M. Rial,1 N. Ambrosi,2 F. Caro,2 D. Curcio,1 J. Salaberry,2 O. Guardia,1 A. Dotta,1 D. Guerrieri,2 K. Padros,3 E. Chuluyan,2 D. Casadei.

    1Instituto de Nefrología, Nephrology, Buenos Aires, Argentina; 2CEFYBO, Facultad de Medicina, UBA-CONICET, Buenos Aires, Argentina; 3PRICAI, Fundación Favaloro, Buenos Aires, Argentina.

    Belatacept, a fusión protein that blocks the B7-CD28 costimulation pathway, decreases the level of antibodies in non-human primates and murine models but, few studies have…
  • 2016 American Transplant Congress

    IVIG and High Dose Steroid Treatment of Transplant Glomerulopathy Effectively Slows Progression of Loss of Renal Allograft Function.

    K. Sablik,1 C. Looman,2 M. Clahsen-van Groningen,3 J. Damman,3 D. Roelen,4 M. van Agteren,1 M. Betjes.1

    1Nephrology and Transplantation, Erasmus MC University Center, Rotterdam, Netherlands; 2Biostatistics, Erasmus MC University Center, Rotterdam, Netherlands; 3Pathology, Erasmus MC University Center, Rotterdam, Netherlands; 4Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

    Introduction Transplant glomerulopathy (TG) is commonly associated with chronic antibody mediated rejection and is a major cause of late kidney allograft loss with no established…
  • 2016 American Transplant Congress

    Virtual Crossmatching Under the New KAS: Safely Bypassing a Physical Crossmatch When Allocating Kidneys to Highly Sensitized Candidates.

    R. Bray,1 R. Parsons,2 N. Turgeon,2 H. Gebel.1

    1Pathology, Emory University, Atlanta, GA; 2Emory Transplant Center, Emory University, Atlanta, GA.

    AIM: On 12/4/2014, the OPTN implemented a new KAS for deceased donor(DD) transplants which, among many changes, increased priority for highly sensitized (HS) candidates (cPRA>98%).…
  • 2016 American Transplant Congress

    Characterization of Vascular Lesions in Living Donor Renal Transplant Implant Biopsies.

    F. Tinney Jr,1 L. Yessayan,2 M. Abouljoud,3 A. Patel.3

    1Wayne State University School of Medicine, Detroit, MI; 2Department of Nephrology, Henry Ford Hospital, Detroit, MI; 3Transplant Institute, Henry Ford Hospital, Detroit, MI.

    INTRODUCTION: Nephrosclerosis is often associated with pathological injury to kidneys resulting from chronic high blood pressure and/or aging, and may predict the progression of decline…
  • 2016 American Transplant Congress

    An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?

    J. Siegel,1 A. Humar,2 P. Gianaros,1 J. Steel.2

    1Department of Psychology, University of Pittsburgh, Pittsburgh, PA; 2Department of Surgery, Division of Transplantation, University of Pittsburgh, Pittsburgh, PA.

    Lack of health insurance has been related lack of access to health care, poorer health, and increased mortality. In this study, we investigate sociodemographic predictors…
  • 2016 American Transplant Congress

    Deceased Donor ABO-Incompatible Kidney Transplantation Has the Potential to Reduce Blood Group Disparity.

    M. Manook,1 L. Bradbury,2 D. Osei-Bordom,1 B. Sandhu,1 T. Maggs,1 O. Shaw,1 N. Kessaris,1 S. Shah,3 A. Dorling, N. Mamode.1

    1Guy's & St Thomas' Hospital, London, United Kingdom; 2NHS Blood & Transplant, Bristol, United Kingdom; 3King's College Hospital, London, United Kingdom.

    Introduction: Patients with blood group O or B wait significantly longer for a kidney transplant than other groups. Blood group incompatible transplantation is widely accepted…
  • « Previous Page
  • 1
  • …
  • 408
  • 409
  • 410
  • 411
  • 412
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences